SHB.B

218.6

+1.11%↑

SWED.A

320.6

-1.23%↓

SCA.A

126.4

+1.2%↑

EVO

602.4

+0.8%↑

SKF.B

223.1

-2.66%↓

SHB.B

218.6

+1.11%↑

SWED.A

320.6

-1.23%↓

SCA.A

126.4

+1.2%↑

EVO

602.4

+0.8%↑

SKF.B

223.1

-2.66%↓

SHB.B

218.6

+1.11%↑

SWED.A

320.6

-1.23%↓

SCA.A

126.4

+1.2%↑

EVO

602.4

+0.8%↑

SKF.B

223.1

-2.66%↓

SHB.B

218.6

+1.11%↑

SWED.A

320.6

-1.23%↓

SCA.A

126.4

+1.2%↑

EVO

602.4

+0.8%↑

SKF.B

223.1

-2.66%↓

SHB.B

218.6

+1.11%↑

SWED.A

320.6

-1.23%↓

SCA.A

126.4

+1.2%↑

EVO

602.4

+0.8%↑

SKF.B

223.1

-2.66%↓

Search

Ratos AB (Class B)

Închisă

32.62 -1.69

Rezumat

Modificarea prețului

24h

Curent

Minim

32.62

Maxim

32.7

Indicatori cheie

By Trading Economics

Venit

-2.1B

-1.7B

Vânzări

436M

4.6B

P/E

Medie Sector

11.333

55.155

EPS

0.37

Randament dividend

3.87

Marjă de profit

-37.883

Angajați

8,591

EBITDA

-870M

136M

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.87%

4.95%

Statistici piață

By TradingEconomics

Capitalizare de piață

17M

12B

Deschiderea anterioară

34.31

Închiderea anterioară

32.62

Ratos AB (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 apr. 2026, 23:17 UTC

Câștiguri

Samsung Forecasts Record First-Quarter Operating Profit

6 apr. 2026, 23:00 UTC

Acțiuni populare

Stocks to Watch: Health Insurers, Mawson, Owlet

6 apr. 2026, 22:13 UTC

Principalele dinamici ale pieței

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 apr. 2026, 21:46 UTC

Achiziții, Fuziuni, Preluări

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 apr. 2026, 17:09 UTC

Principalele dinamici ale pieței

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 apr. 2026, 16:56 UTC

Evenimente importante

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 apr. 2026, 14:47 UTC

Principalele dinamici ale pieței

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 apr. 2026, 00:00 UTC

Evenimente importante

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 apr. 2026, 23:58 UTC

Market Talk
Evenimente importante

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 apr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 apr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 apr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 apr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 apr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 apr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 apr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 apr. 2026, 18:36 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 17:59 UTC

Market Talk
Evenimente importante

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 apr. 2026, 17:13 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 apr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 apr. 2026, 14:59 UTC

Câștiguri

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparație

Modificare preț

Ratos AB (Class B) Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Ratos AB (Class B)

Ratos AB (publ) is a private equity firm specializing in buyouts, turnarounds, add on acquisitions, and middle market transactions. The firm does not invest in early stages and in companies that operate in the arms industry, pornography, or are detrimental to the environment. It seeks to invest in unlisted medium sized companies. The firm invests in industry, construction and services, consumer, and technology sectors. The firm typically invests in the Nordic region, with focus on Sweden, Finland, Denmark, and Norway. It seeks to invest in companies with equity investments between SEK250 million ($23.57 million) and SEK5000 million ($471.57 million), sales value between SEK300 million ($28.29 million) and SEK5000 million ($471.57 million) and EBITDA greater than SEK50 million ($4.71 million). The firm takes both minority and majority stakes. The firm prefers to be the principal owner with a minimum holding of at least 20 percent and also seeks a board seat. It prefers to hold its investment between five to ten years. Ratos AB (publ) was founded in 1934 and is based in Stockholm, Sweden.
help-icon Live chat